Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 00:42 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Lefamulin for M. Genitalium Treatment Failures
NCT05111002 · University of Washington · PHASE1/PHASE2 · terminated · last registry update 2024-10-26 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “At Sponsor Request” | – | Registry record, University of Washington |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against MMP7 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2025-10-01Phase 3 first posted: Monash University, Trimethoprim / Sulfamethoxazole + Immune Globulin Intravenous (NCT07202078)
- 2025-10-01Phase 3 first posted: Monash University, Trimethoprim Sulfamethoxazole + Amoxycillin/clavulanic acid (NCT07202091)
- 2025-10-01Phase 3 first posted: Monash University, Intravenous immunoglobulin + Trimethoprim / Sulfamethoxazole (NCT07202052)
- 2025-09-11Results posted on the registry: Emory University, Doxycycline (NCT05853120)
- 2025-08-28Also stopped (terminated): Public Health Foundation Enterprises, Inc., a drug against MMP7 (NCT07146139)
- 2025-08-26Results posted on the registry: West Virginia University, Amoxicillin, amoxicillin-clavulanate, cefadroxil, cefpodoxime, cefalexin, ciprofloxacin, delafloxacin, doxycycline, levofloxacin, linezolid + Ampicillin, ampicillin-sulbactam, cefazolin, cefepime, ceftaroline, ceftazidime, ceftazidime-avibactam, dalbavancin, daptomycin, ertapenem (NCT05977868)
- 2025-08-26Also stopped (terminated): West Virginia University, Amoxicillin, amoxicillin-clavulanate, cefadroxil, cefpodoxime, cefalexin, ciprofloxacin, delafloxacin, doxycycline, levofloxacin, linezolid + Ampicillin, ampicillin-sulbactam, cefazolin, cefepime, ceftaroline, ceftazidime, ceftazidime-avibactam, dalbavancin, daptomycin, ertapenem (NCT05977868)
- 2025-06-22Results posted on the registry: PolyPid Ltd., D-PLEX + Standard of Care (SoC) (NCT04233424)
- 2024-12-03Results posted on the registry: Journey Medical Corporation, DFD-29 + Doxycycline (NCT05296629)
- 2024-12-03Results posted on the registry: Journey Medical Corporation, DFD-29 + Doxycycline (NCT05343455)
- 2024-07-12Results posted on the registry: University of California, San Francisco, Doxycycline Hyclate Delayed-Release 200 mg (NCT03980223)
- 2024-07-11Also stopped (terminated): Fondazione IRCCS Policlinico San Matteo di Pavia, Doxycycline + Standard of care therapy (NCT03474458)
- 2024-07-10Results posted on the registry: University of Washington, Doxycycline (NCT04050540)
- 2024-07-03Also stopped (withdrawn): University of California, Davis, Rituximab combined with Omalizumab (NCT04128176)
- 2024-06-07Phase 3 first posted: Centre Hospitalier Universitaire de Nice, ISOtretinoin 5 MG + Topical cream (NCT06447480)
- 2024-04-05Phase 3 first posted: Assistance Publique Hopitaux De Marseille, Azithromycin + Ceftriaxone (NCT06349122)
- 2024-01-23Results posted on the registry: Sorlandet Hospital HF, Doxycycline + Placebo (NCT02553473)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision